Experiment 635414
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | LIU,SM: AJANI,U: CHAE,C: HENNEKENS,C: BURING,JE: MANSON,JE:. (1999). LONG-TERM BETA-CAROTENE SUPPLEMENTATION AND RISK OF TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROLLED TRIAL.. 282(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | RANDIMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL ASSESSED THE EFFICACY OF B-CAROTENE TO PREVENT DIABETES MELLITUS. SUBJECTS WERE RANDOMLY ASSIGNED TO RECEIVE B-CAROTENE (50 MG ON ALTERNATE DAYS OR PLACEBO. RELATIVE RISK WAS 0.98;95% CONFIDENCE INTERVAL, 0.85-1.12%. THE RESULTS SHOWED THAT SUPPLEMENTATION WITH B-CAROTENE FOR AN AVERAGE OF 12 YEARS HAD NO EFFECT ON THE RISK OF SUBSEQUENT TYPE 2 DIABETES MELLITUS. |
| Dose amount | 50.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | MALE |